The European Commission proposed on Tuesday 16 March that the delivery of 10 million doses of the Covid-19 vaccine produced by Pfizer-BioNTech be accelerated. It suggests taking this amount from the option of 100 million doses to be delivered in the third and fourth quarters and bringing it forward to the second quarter of the year.
This advance, which still needs to be approved by Member States, would bring the total number of doses supplied by Pfizer-BioNTech in the second quarter...